XML 47 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 27, 2020
Mar. 29, 2019
Mar. 27, 2020
Mar. 29, 2019
Income Statement [Abstract]        
Revenue $ 3,731,559 $ 3,999,987 $ 7,985,156 $ 8,265,336
Costs and Expenses:        
Cost of services provided 3,407,589 3,639,959 7,175,702 7,434,404
Depreciation and amortization 147,975 147,908 295,911 298,629
Goodwill impairment 198,600 0 198,600 0
Selling and general corporate expenses 75,071 88,285 158,326 192,415
Gain on sale of Healthcare Technologies 0 1,000 0 (156,309)
Operating Expenses, Total 3,829,235 3,877,152 7,828,539 7,769,139
Operating (loss) income (97,676) 122,835 156,617 496,197
Interest and Other Financing Costs, net 99,822 84,178 179,407 167,155
(Loss) Income Before Income Taxes (197,498) 38,657 (22,790) 329,042
Provision for Income Taxes 4,523 9,347 33,348 49,054
Net (loss) income (202,021) 29,310 (56,138) 279,988
Less: Net income (loss) attributable to noncontrolling interest 239 (43) 361 (49)
Net (loss) income attributable to Aramark stockholders $ (202,260) $ 29,353 $ (56,499) $ 280,037
(Loss) Earnings per share attributable to Aramark stockholders:        
Basic (in dollars per share) $ (0.80) $ 0.12 $ (0.23) $ 1.14
Diluted (in dollars per share) $ (0.80) $ 0.12 $ (0.23) $ 1.11
Weighted Average Shares Outstanding:        
Basic (in shares) 252,354 246,217 250,543 246,540
Diluted (in shares) 252,354 250,347 250,543 251,355